| #132 |
Mazen Abdin |
Dcs Copy Protection Limited |
4 |
| #132 |
Conrad VINK |
Glaxosmithkline Intellectual Property Development Limited |
4 |
| #132 |
David Conti |
Robart Gmbh |
4 |
| #132 |
Seble Lemma |
Glaxosmithkline Intellectual Property Development Limited |
4 |
| #132 |
Bhupendra Lodhia |
Autodesk |
4 |
| #132 |
Amanda Jennifer Campbell |
Glaxo Group Limited |
4 |
| #132 |
Hugo R Simpson |
Mbda Uk Limited |
4 |
| #132 |
Emiliangelo Ratti |
Glaxo Wellcome S.A. |
4 |
| #132 |
Graham Patrick Wallis |
British Aerospace Public Limited |
4 |
| #132 |
Richard Jonathan Hatley |
Glaxo Group Limited |
4 |
| #161 |
Peter J. Holness |
Unknown |
3 |
| #161 |
John E. Gaywood |
British Aerospace Public Limited |
3 |
| #161 |
Ian Martin Mutton |
Glaxo Group Limited |
3 |
| #161 |
Kate Butchart |
Cerebrus Solutions Limited |
3 |
| #161 |
Markus Schober |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #161 |
Peter G. Foulsham |
British Aerospace Public Limited |
3 |
| #161 |
Arthur G. Boon |
— |
3 |
| #161 |
Peter W. Busby |
British Aerospace Public Limited |
3 |
| #161 |
Enoch James |
British Aerospace Public Limited |
3 |
| #161 |
Tomoaki KURAKAZU |
Asahi Rubber |
3 |
| #161 |
Nicholas Paul BARTON |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #161 |
Chiok Keng Leong |
Airbus Defence And Space Gmbh |
3 |
| #161 |
Etienne Levernier |
Glaxosmithkline Intellectual Property (No. 4) Limited |
3 |
| #161 |
David Parry-Jones |
Astex Therapeutics Limited |
3 |
| #161 |
Alessandra Giarola |
Case Western Reserve University |
3 |
| #161 |
Edwin John William BOWDEN-PETERS |
Mbda Uk Limited |
3 |
| #161 |
Laura Hook |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #161 |
Chika Akinseye |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #161 |
Maria Feeney |
Glaxo Group Limited |
3 |
| #161 |
Gary Peter Bembridge |
Glaxo Group Limited |
3 |
| #161 |
Anthony William Dean |
Glaxo Group Limited |
3 |
| #161 |
Steve Tate |
Airbus Defence And Space Gmbh |
3 |
| #161 |
Caroline Dimech |
Glaxo Group Limited |
3 |
| #161 |
Steven Ludbrook |
Smithkline Beecham Limited |
3 |
| #161 |
Carmel Horgan |
Smithkline Beecham Limited |
3 |
| #161 |
Paul F. Life |
Smithkline Beecham Limited |
3 |
| #161 |
Rossella Guidetti |
Eli Lilly |
3 |
| #161 |
Ian Richard Catchpole |
Glaxo Group Limited |
3 |
| #161 |
Mei-yin Lee |
Glaxo Group Limited |
3 |
| #161 |
Rachael Anne Ancliff |
Glaxo Group Limited |
3 |
| #161 |
Sheila Bronwen Flynn |
Btg International |
3 |
| #161 |
Andrew McM Mason |
Biota Scientific Management Pty |
3 |
| #161 |
Joanna Mary Redmond |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #161 |
Edward Duncan Blair |
Glaxo Group Limited |
3 |
| #161 |
Caroline Jane Day |
Glaxo Group Limited |
3 |
| #161 |
James Bailey |
Glaxosmithkline |
3 |
| #161 |
Jeremy David Alistair Kitson |
Glaxo Group Limited |
3 |
| #161 |
Yannick Maurice Lacroix |
Glaxo Group Limited |
3 |
| #161 |
Stuart Neville Farrow |
Glaxo Group Limited |
3 |
| #161 |
Stefano Livia |
Glaxo Group Limited |
3 |